About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDPhase 2NCT03747497

Contezolid Acefosamil Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection

The purpose of this study is to determine whether contezolid acefosamil is as safe and effective as linezolid in the treatment of adult patients with acute bacterial skin and skin structure infections

Lead sponsor: MicuRx•7 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

MicuRx

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Patients with systemic signs of infection diagnosed with acute bacterial skin and skin structure infection (ABSSSI)
•Diagnosed with cellulitis/erysipelas, major cutaneous abscess, or wound infections

Exclusion Criteria

•Uncomplicated skin infections
•Severe sepsis or septic shock
•ABSSSI solely due to Gram-negative pathogens
•Prior systemic antibiotics within 96 hours of randomization

Related studies

Fosfomycin I.v. for Treatment of Severely Infected Patients

NCT02979951 · Bacterial Infections, Bone Diseases, Infectious, and more

Drug Exposure and Minimum Inhibitory Concentration in the Treatment of MAC Lung Disease

NCT05824988 · Mycobacterium Avium Complex, Mycobacterium Avium-Intracellulare Infection, and more

COMPLETEDPhase 1

Open Label, Dose-finding, Pharmacokinetics, Safety and Tolerability Study of Oritavancin in Pediatric Participants With Suspected or Confirmed Bacterial Infections

NCT02134301 · Gram-positive Bacterial Infections

Clinical Decision Support Tool for Vancomycin Dosing in Children

NCT04911270 · Gram-Positive Bacterial Infections, Vancomycin, and more

COMPLETEDPhase 2

TNP-2092 to Treat Acute Bacterial Skin and Skin Structure Infection

NCT03964493 · Skin and Subcutaneous Tissue Bacterial Infections, Gram-Positive Bacterial Infections

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 8, 2022Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment196

Start dateNov 2018

Last updatedNov 8, 2022

Condition

Skin Diseases, Bacterial Gram-Positive Bacterial Infections

Locations shown

MicuRx Site #106

Chula Vista, California

MicuRx Site #103

La Mesa, California

MicuRx Site #102

Long Beach, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 8, 2022Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions